Oral anticoagulant drugs: do not cut tablets in quarters
Biron, C.; Licznar, P.; Hansel, S.; Schved, J.F.
Thrombosis and Haemostasis 82(3): 1201
1999
ISSN/ISBN: 0340-6245 PMID: 10494792 Document Number: 500229
Document emailed within 1 workday
Related Documents
Ammar, H.O.; Ghorab, M.; el-Nahhas, S.A.; Makram, T.S. 1997: Improvement of the biological performance of oral anticoagulant drugs. 2. Dicumarol Die Pharmazie 52(9): 727-728Nyqvist, H.; Lundgren, P.; Nyström, C.; Wadsten, T. 1978: Studies on the physical properties of tablets and tablet excipients. I. Adsorption of drugs to cellulose used in tablets Acta Pharmaceutica Suecica 15(2): 150-159
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Kaiko, R.F.; Fitzmartin, R.D.; Thomas, G.B.; Goldenheim, P.D. 1992: The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets PharmacoTherapy 12(2): 107-113
Wynn, R.L. 2012: New antiplatelet and anticoagulant drugs General Dentistry 60(1): 8-11
Haas, S. 2005: New anticoagulant drugs: a critical perspective Current Hematology Reports 4(5): 335-338
Yamamoto, K. 2010: Anticoagulant or antiplatelet drugs and anesthesia Masui. Japanese Journal of Anesthesiology 59(9): 1160-1165
Bourde, C. 1970: Use and misuse of anticoagulant drugs in phlebitis Marseille Medical 107(12): 1009-1011
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Sellers, E.M.; Koch-Weser, J. 1972: Oral anticoagulant therapy Canadian Medical Association Journal 106(4): 302 Passim
Cid, E. 1974: Factors influencing the bioavailability of drugs in the form of tablets Pharmaceutica Acta Helvetiae 49(9-10): 285-292
Blinder, D.; Martinowitz, U.; Ardekian, L.; Peleg, M.; Taicher, S. 1996: Oral surgical procedures during anticoagulant therapy Harefuah 130(10): 681
Vermeer, C. 1982: Side effects of oral anticoagulant therapy? Nederlands Tijdschrift Voor Geneeskunde 126(52): 2394
Thornes, R.D. 1974: Oral anticoagulant therapy of human cancer Journal of Medicine 5(1): 83-91
Hummel, L. 1988: Problems of the laboratory control of oral anticoagulant treatment Folia Haematologica 115(4): 529-531
Birger, A.; Engelberg, I. 1986: Rare side-effects of oral anticoagulant therapy Harefuah 111(5-6): 120-122
Jha, V.K.; Jairam, A.; Mahapatra, D. 2019: Newer Oral Anticoagulant in Chronic Kidney Disease: what we Should know Journal of the Association of Physicians of India 67(11): 60-65
Sawyer, P.N.; Stanczewski, B.; Pomerance, A.; Stoner, G.; Srinivasan, S. 1973: Utility of anticoagulant drugs in vascular thrombosis: electron microscopic and biophysical study Surgery 74(2): 263-275
Blower, P. 1995: A pharmacologic profile of oral granisetron (Kytril tablets) Seminars in Oncology 22(4 Suppl 10): 3-5